Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 3
1976 1
1977 4
1978 2
1979 1
1980 6
1981 3
1982 1
1983 1
1984 3
1985 3
1986 2
1988 2
1991 1
1995 2
2012 1
2013 4
2015 2
2017 1
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T; Ellipse Trial Investigators. Tamborlane WV, et al. N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28. N Engl J Med. 2019. PMID: 31034184 Clinical Trial.
Diabetes in Kentucky.
Leichter SB, Hernandez C, Fisher A, Collins P, Courtney A. Leichter SB, et al. Diabetes Care. 1982 Mar-Apr;5(2):126-34. doi: 10.2337/diacare.5.2.126. Diabetes Care. 1982. PMID: 6927720
Alimentary hypoglycemia: a new appraisal.
Leichter SB. Leichter SB. Am J Clin Nutr. 1979 Oct;32(10):2104-14. doi: 10.1093/ajcn/32.10.2104. Am J Clin Nutr. 1979. PMID: 384782 Review.
Institutional commitment to diabetes care.
Leichter SB. Leichter SB. South Med J. 1980 Mar;73(3):276-7. doi: 10.1097/00007611-198003000-00002. South Med J. 1980. PMID: 7361127 No abstract available.
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators. Ridker PM, et al. N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304242 Free article. Clinical Trial.
Clinical and metabolic aspects of glucagonoma.
Leichter SB. Leichter SB. Medicine (Baltimore). 1980 Mar;59(2):100-13. doi: 10.1097/00005792-198003000-00002. Medicine (Baltimore). 1980. PMID: 6987481
Management of hyperlipidemia in diabetes.
Vinik AI, O'Brian JT, Georges LP, Leichter SB, Janin Y. Vinik AI, et al. Among authors: leichter sb. Compr Ther. 1995 Oct;21(10):602-9. Compr Ther. 1995. PMID: 8565431 Review. No abstract available.
46 results